NON-SMALL CELL LUNG CANCER METASTATIC

This adverse event was reported 879 times

These drugs are most commonly taken by patients reporting NON-SMALL CELL LUNG CANCER METASTATIC:

# Drug Count
0 CARBOPLATIN 124
1 SOTORASIB 98
2 PEMETREXED DISODIUM 88
3 PEMETREXED 70
4 PACLITAXEL 63
5 BEVACIZUMAB 60
6 CRIZOTINIB 52
7 PACLITAXEL (AIBUMIN-BOUND) 49
8 METHOTREXATE SODIUM 46
9 OSIMERTINIB 43
See all common drugs associated with NON-SMALL CELL LUNG CANCER METASTATIC

NON-SMALL CELL LUNG CANCER METASTATIC is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SOTORASIB 98 0.0282
1 AMIVANTAMAB-VMJW 35 0.0098
2 CERITINIB 17 0.0071
3 BRIGATINIB 21 0.0057
4 CAPMATINIB 12 0.0051
5 LORLATINIB 37 0.0050
6 CRIZOTINIB 52 0.0041
7 ALDESLEUKIN 4 0.0032
8 ERLOTINIB HYDROCHLORIDE 39 0.0031
9 PEMETREXED DISODIUM 88 0.0023
See all drugs enriched for association with NON-SMALL CELL LUNG CANCER METASTATIC